openPR Logo
Press release

Global Preimplantation Genetics Diagnosis (PGD) Market Analysis Report 2019 by Size, Share, Growth and Assessment to 2022

01-14-2019 05:57 PM CET | Health & Medicine

Press release from: Allied Market Research

Global Preimplantation Genetics Diagnosis (PGD) Market

Preimplantation genetic diagnosis (PGD) also referred to as embryo screening, is a branch of genetics involves in genetic testing of the embryo through In-Vitro Fertilization (IVF). PGD eliminates the risk of selective pregnancy termination for couples who are at substantial risk of transferring serious genetic, chromosomal or hereditary disorders such as spinal muscular atrophy and cystic fibrosis.

Get the sample report: https://www.alliedmarketresearch.com/request-sample/1470?utm_source=openpr&utm_medium=Niranjan

Preimplantation Genetic Diagnosis Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $121 million by 2022, registering a CAGR of 6.14% during the period 2016-2022.

Around 30 to 60% of the human embryos have chromosomal abnormalities. They usually occur in women aged 40 and above. Moreover, chromosomal abnormalities are also seen in working women due to the hectic lifestyle patterns which increase the demand of various diagnostic procedures including PGD.

According to the World Health Organization (WHO), around 48.5 million couples worldwide were unable to conceive a child in 2010. Furthermore, increasing risk of fatal genetic, hereditary, and chromosomal diseases such as Duchenne muscular dystrophy, down syndrome, cystic fibrosis, triploidy, and thalassemia promote patients to opt for PGD thereby, boosting the market growth worldwide.

Purchase report @Discount: https://www.alliedmarketresearch.com/checkout/231524?utm_source=openpr&utm_medium=Niranjan

Furthermore, an increase in awareness about the innovative and advanced application of PGD in developing countries such as China and India offers enormous opportunities for market growth. A rise in awareness about the various genetic disorders and chromosomal abnormalities have increased the demand for diagnostic procedures including PGD.

Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Geographically, Europe holds the highest potential to generate major revenue of the global market accounting for about 31.8% share in 2015. While Asia-Pacific is the fastest growing region registering a CAGR of 6.7%.

Key Findings of Preimplantation Genetics Diagnosis Market Study:

Around 30% to 60% of the human embryos have chromosomal abnormalities. Chromosomal abnormalities in the embryo usually occur in the women aged 40 or over.

Almost 33% of the top strategies were merger and acquisition; whereas, business expansion, partnership, and product launch accounted for 25%, 22.22%, and 19.44% respectively of the overall key strategies.

Pricing of PGD tests is expected to witness a decline with an increase in the volume of PGD testing

Chromosomal Abnormalities test generates the largest share in terms of revenue for PGD market

HLA Typing and Gender Selection based tests are the two fastest-growing segments within Preimplantation Genetics Diagnosis market.

The key market players are F. Hoffmann-La Roche AG, Reprogenetics, LLC, Genea Limited, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer, Inc., Quest Diagnostics Incorporated, Genesis Genetics Ltd., and Reproductive Genetics Innovations LLC.

Chapter: 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments:
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings
3.2.1 Top impacting factor
3.2.2 Top winning strategies
3.2.3 Top investment pockets
3.3 Porters five forces analysis
3.3.1 Low bargaining power of suppliers due to a large number of suppliers and moderate switching cost
3.3.2 Moderate bargaining power of buyers due to a large number of buyers, high product dependency and moderate switching cost.
3.3.3 Moderate threat of substitutes due to ease of substitution, a moderate price war, and high brand loyalty
3.3.4 Low threat of new entrants due to the presence of dominant players and high investment cost and legal barriers
3.3.5 Presence of numerous players, high growth rate and high economic base increases the competition among rivalries
3.4 Drivers
3.4.1 Effective solution for the healthy embryos
3.4.2 Increasing infertility rate and genetic, hereditary and chromosomal diseases
3.4.3 Innovative and wide range of applications such as the development of savior siblings and gender selection among others
3.5 Restraints
3.5.1 Stringent regulations and ethical concerns
3.5.2 High cost incurred and risk involved in PGD
3.6 Opportunities
3.6.1 Increasing adoption of PGD in developing countries

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Preimplantation Genetics Diagnosis (PGD) Market Analysis Report 2019 by Size, Share, Growth and Assessment to 2022 here

News-ID: 1496215 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for PGD

Preimplantation Genetic Diagnostics (PGD) Market | ABBott Laboratories, Agilent …
The global preimplantation genetic diagnostics (pgd) market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the preimplantation genetic diagnostics (pgd) market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving
Preimplantation Genetics Diagnosis (PGD) Market Key Findings, Growth Strategy, T …
Preimplantation Genetics Diagnosis (PGD) Market - Overview The size of the preimplantation genetics diagnosis (PGD) market has been estimated to grow at a significant speed in the forthcoming years. This rapid growth in the market is on the basis of the high accuracy of the PGD in order to detect genetic disorders. In addition to this, increasing investment to detect genetic disorders along with chromosomal abnormalities around the world is also
Preimplantation Genetics Diagnosis (PGD) Market Current Scenario Trends, Compreh …
Preimplantation Genetics Diagnosis (PGD) Market - Overview The size of the preimplantation genetics diagnosis (PGD) market has been estimated to grow at a significant speed in the forthcoming years. This rapid growth in the market is on the basis of the high accuracy of the PGD in order to detect genetic disorders. In addition to this, increasing investment to detect genetic disorders along with chromosomal abnormalities around the world is also
Preimplantation Genetics Diagnosis (PGD) Market: Increasing Demand for Efficient …
The world PGD market is expected to witness notable growth in the coming years owning to the rising prevalence of genetic, hereditary and chromosomal diseases. Moreover, PGD have high chances of conceiving healthy embryos. However, the high costs incurred in the PGD technologies hamper the growth of the market. Moreover, stringent government regulations and ethical concerns also obstruct the growth of the market. In coming years, there would be increase
01-20-2020 | Health & Medicine
CRIFAX
Preimplantation Genetic Diagnosis (PGD) Market – Industry Growth Analysis & Fo …
CRIFAX added a report on ‘Preimplantation Genetic Diagnosis (PGD) Market Analysis Report, Global Outlook (U.S., Canada, UK, Germany, France, Italy, Spain, Netherlands, Russia, China, India, Japan, Australia, South Korea, Malaysia, Brazil, Mexico, Argentina, GCC, South Africa), Growth Potential, Competitive Market Share & Forecast, 2019 – 2028’to its database of market research collaterals consisting of overall market scenario with prevalent and future growth prospects, among other growth strategies used by key
Preimplantation Genetic Diagnosis Market : Asia PGD Market To Witness Highest Tr …
Rising numbers of assisted reproductive procedures such as in vitro fertilization (IVF) is Asia is the most prominent factor driving the market for preimplantation genetic diagnosis. This is, in essence, the result of factors such as the delayed age of conception among Asian women, the rising rate of infertility among the population, and the significantly expanding medical tourism industry in the region. Rising disposable incomes and increased awareness regarding the